IT1270976B - INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM - Google Patents

INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Info

Publication number
IT1270976B
IT1270976B ITMI931806A ITMI931806A IT1270976B IT 1270976 B IT1270976 B IT 1270976B IT MI931806 A ITMI931806 A IT MI931806A IT MI931806 A ITMI931806 A IT MI931806A IT 1270976 B IT1270976 B IT 1270976B
Authority
IT
Italy
Prior art keywords
acyl
cholesterol
contain
pharmaceutical compositions
therapeutic activities
Prior art date
Application number
ITMI931806A
Other languages
Italian (it)
Inventor
Massimiliano Palladino
Ermes Vandotti
Manuela Villa
Massimo Bani
Rita Bometti
Vincenzo Olgiati
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Priority to ITMI931806A priority Critical patent/IT1270976B/en
Publication of ITMI931806A0 publication Critical patent/ITMI931806A0/en
Priority to GB9415873A priority patent/GB2280675A/en
Priority to JP6204436A priority patent/JPH07149733A/en
Priority to DE4428025A priority patent/DE4428025A1/en
Publication of ITMI931806A1 publication Critical patent/ITMI931806A1/en
Application granted granted Critical
Publication of IT1270976B publication Critical patent/IT1270976B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI931806A 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM IT1270976B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITMI931806A IT1270976B (en) 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
GB9415873A GB2280675A (en) 1993-08-06 1994-08-05 ACAT-inhibiting imidazoles
JP6204436A JPH07149733A (en) 1993-08-06 1994-08-05 Acyl enzyme-a-cholesterol-o-acyl-transferase inhibitor compound having therapeutic activity, its use and pharmaceutical composition containing it
DE4428025A DE4428025A1 (en) 1993-08-06 1994-08-08 Inhibitors of acyl-enzyme-A-cholesterol O-acyl-transferase with therapeutic activity, their use and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI931806A IT1270976B (en) 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Publications (3)

Publication Number Publication Date
ITMI931806A0 ITMI931806A0 (en) 1993-08-06
ITMI931806A1 ITMI931806A1 (en) 1995-02-06
IT1270976B true IT1270976B (en) 1997-05-26

Family

ID=11366803

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI931806A IT1270976B (en) 1993-08-06 1993-08-06 INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Country Status (4)

Country Link
JP (1) JPH07149733A (en)
DE (1) DE4428025A1 (en)
GB (1) GB2280675A (en)
IT (1) IT1270976B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL149145A0 (en) * 1999-11-05 2002-11-10 Warner Lambert Co Prevention of plaque rupture by acat inhibitors
US7884106B2 (en) 2003-08-29 2011-02-08 Kowa Company, Ltd. Method of stabilizing lipid-rich plaque and method of preventing rupture thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248528B (en) * 1991-06-21 1995-01-19 Pierrel Spa AROMATIC ETHER AND THIOETHER (HETER) DERIVATIVES HAVING ANTI-HYPERLIPIDEMIC ACTIVITY, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
ITMI931806A0 (en) 1993-08-06
ITMI931806A1 (en) 1995-02-06
DE4428025A1 (en) 1995-02-09
GB9415873D0 (en) 1994-09-28
JPH07149733A (en) 1995-06-13
GB2280675A (en) 1995-02-08

Similar Documents

Publication Publication Date Title
NO305537B1 (en) Pharmaceutical preparation containing a defined lipid system and use of the lipid system
AR027162A1 (en) COMPOUNDS OF 2-PHENYL-3-PHENOXYL-PHENYLTIO-BENZOTIOFEN, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CA2293382A1 (en) Piperazine derivatives and their use as anti-inflammatory agents
BR1100329A (en) Compound and pharmaceutical formulation
PT589843E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORTS
GB9206736D0 (en) Improvements of organic compounds and their use in pharmaceutical compositions
MA26553A1 (en) ALPHA-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HUP0004644A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase and pharmaceutical compositions containing them
HUP0102025A3 (en) Derivatives of 1,3,4-oxadiazolone, pharmaceutical compositions containing them and their use
IT8948430A0 (en) TRIPEPTIDE COMPOUNDS AND THEIR PHARMACEUTICAL USE AS IMMUNO-MODULATORS
IT1297205B1 (en) PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN WITH IMPROVED ABSORPTION, THEIR PREPARATION AND THEIR USE
FI944933A0 (en) 7-Disubstituted methyl-4-oxo-3H, 5H-pyrrolo (3,2-d) pyrimidine and pharmaceutical uses and compositions containing it
IT1270976B (en) INHIBITIVE COMPOUNDS OF ACYL ENZYME-A-CHOLESTEROL-O-ACYL TRANSFERASE TO THERAPEUTIC ACTIVITIES, THEIR USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ZA933426B (en) New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them
IL114208A0 (en) Combinations of compounds pharmaceutical compositions containing them and their use as hiv protease inhibitors
IT1290003B1 (en) USE OF PIVAGABINA TO PREPARE PHARMACEUTICAL COMPOSITIONS
ITFI920134A0 (en) 7-NEOPERENTIL XANTHINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ITMI931082A0 (en) CONJUGATES OF ANTIVIRAL DRUGS WITH HEPATOTROPIC ACTIVITYQ AND RELATED CARRIERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ITMI910978A1 (en) PHARMACOLOGICAL ACTIVITIES OF PYRIMIDINE, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ITMI911930A0 (en) PHARMACEUTICAL COMPOSITIONS OF OXYRACETAM STEREOISOMERS AND THEIR THERAPEUTIC USE
IT1290840B1 (en) PHARMACEUTICAL COMPOSITIONS SPRAY FOR THE APPLICATION OF FORMULAS FOR TOPICAL USE CONTAINING ESCINA
ITMI922216A0 (en) NITROBENZOYLALANINE PROCEDURE FOR THEIR PREPARATION THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
ITMI920660A0 (en) NEW DERIVATIVE OF L-VERBENONE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
ITMI921950A1 (en) PHARMACEUTICAL COMPOSITIONS WITH HEPATO-TROPHIC AND ANTI-AGING ACTIVITIES
ITMI932767A1 (en) POLYCYCLIC DERIVATIVES OF OXO-AZASTEROIDS INHIBITORS OF THE 5-ALPHA REDUCED ENZYME, THEIR USE AS ANTIANDROGENS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960830